↓ Skip to main content

A prospective, randomized, phase II study to assess the schemas of retreatment with Lutathera® in patients with new progression of an intestinal, well-differentiated neuroendocrine tumor (ReLUTH)

Overview of attention for article published in BMC Cancer, December 2022
Altmetric Badge

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
14 Mendeley